Notifications
Back
Notification settings
Back
More
Post notifications
Post reactions
Be notified when someone leaves a comment or a reply to your post or comment.
Updates and news
Stay ahead of important updates and news from the site.
  • Alarm
    Profile image
  • My account Sign out
    Sign-in required.
  • About Us
    • Overview
    • History
    • Management
    • Investors
  • R&D
    • Technology
    • Pipeline
    • Publications
  • Business
    • Partnership
    • How to collaborate
  • IR/PR
    • Notice
    • Press release
  • Contact
    • Contact Us
    • Location
  • About Us
    • Overview
    • History
    • Management
    • Investors
  • R&D
    • Technology
    • Pipeline
    • Publications
  • Business
    • Partnership
    • How to collaborate
  • IR/PR
    • Notice
    • Press release
  • Contact
    • Contact Us
    • Location
MENU
AbTis
site search

A Leading ADC Biotech Company

with the World Best Linker Platform Technology
TECHNOLOGY
PRESS RELEASE

AbTis has developed 3rd generation of ADC linker technology, AbClick®.

AbClick® utilizes a cyclic peptide that site-selectively conjugates drugs to natural antibodies without antibody modification. It also controls number of payloads conjugated to the linker for high yield of conjugation and simple process of purification. Therefore, AbClick® leads cost-effective ADC production with a high therapeutic index. 

Lonza, AbTis Partner to Extend Bioconjugation Capabilities Lonza and AbTis, a Korean biotechnology company dedicated to antibody drug conjugates (ADC), are col...
5 Dec 2022
GenScript ProBio-AbTis, Sign a Strategic Cooperation MOU On the January 12, 2022, GenScript ProBio(Brian Ho-sung Min, CEO), a global bio-CRO and CDMO, and Ab...
12 Jan 2022
앱티스, Biotech Showcase 및 Global IR@JPM 참가 ADC(Antibody Drug Conjugate, 항체-약물 복합체) 전문 기업인 앱티스는 제3회 글로벌IR@JPM 행사에 참여 기업으로 최종 선정됐다고 밝혔다. 본 행사는 한국...
3 Jan 2023

AbTis

About Us

  • Overview
  • History
  • Management
  • Investors

R&D

  • Technology
  • Pipeline
  • Publications

Business

  • Partnership
  • How to collaborate

Notice

  • Notice
  • Press release

Contact

  • Contact Us
  • Location

Copyright ⓒ 2023 AbTis.co.,ltd. All rights resered